Fri, February 26, 2021
Thu, February 25, 2021
Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021
Thu, February 18, 2021

Brian Skorney Upgraded (VRTX) to Buy and Increased Target to $252 on, Feb 23rd, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-increased-target-to-252-on-feb-23rd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Skorney of Baird, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy and Increased Target from $220 to $252 on, Feb 23rd, 2021.

Brian has made no other calls on VRTX in the last 4 months.



There are 10 other peers that have a rating on VRTX. Out of the 10 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $250 on, Tuesday, February 2nd, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $251 on, Tuesday, January 19th, 2021


These are the ratings of the 8 analyists that currently disagree with Brian


  • Brian Abrahams of "RBC Capital" Maintained at Buy and Held Target at $264 on, Monday, February 15th, 2021
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $284 on, Tuesday, February 2nd, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $347 on, Tuesday, February 2nd, 2021
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $280 on, Tuesday, February 2nd, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, November 20th, 2020
  • Vincent Chen of "Bernstein" Initiated at Buy and Held Target at $275 on, Friday, November 20th, 2020
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $277 on, Friday, October 30th, 2020
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $307 on, Friday, October 30th, 2020

Publication Contributing Sources